We are live on ! Find out more
CGM

Capital Growth Management Portfolio holdings

AUM $761M
1-Year Est. Return 30.71%
This Fund
S&P 500
This Quarter Est. Return
+14.73%
1 Year Est. Return
+30.71%
3 Year Est. Return
+422.09%
5 Year Est. Return
+672.61%
10 Year Est. Return
AUM
$3.63B
AUM Growth
+$79.5M
Cap. Flow
-$293M
Cap. Flow %
-8.07%
Top 10 Hldgs %
50.06%
Holding
78
New
22
Increased
12
Reduced
12
Closed
19

Top Buys

Rank Stock Value
1
F icon
Ford
F
+$88.3M
2
STLA icon
Stellantis
STLA
+$85M
3
AAL icon
American Airlines Group
AAL
+$65.7M
4
SWKS icon
Skyworks Solutions
SWKS
+$62.3M
5
AMT icon
American Tower
AMT
+$61.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 39.44%
2 Financials 22.98%
3 Real Estate 22.05%
4 Industrials 6.68%
5 Technology 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VFC icon
76
VF Corp
VFC
$5.88B
-515,070
Closed -$32M
SNDK
77
DELISTED
SANDISK CORP
SNDK
-1,080,000
Closed -$106M
WLH
78
DELISTED
WILLIAM LYON HOMES
WLH
-620,000
Closed -$13.7M

Similar funds

Capital Growth Management's Q4 2014 Portfolio in Review

As of Q4 2014, Capital Growth Management held 78 positions worth $3.63B, up 2.2% from $3.55B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Capital Growth Management withdrew a net $293M in Q4 2014, closing 19 positions and reducing 12 holdings. Its most notable exit was Gilead Sciences, an estimated $166M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 39% of assets, up from 35% a quarter earlier, followed by Financials and Real Estate.

Against the trend, Capital Growth Management opened a new position in Stellantis worth $86.6M.

  • Capital Growth Management's largest Q4 2014 buy was Stellantis: 11,472,154 shares worth $86.6M.
  • Capital Growth Management added most to Ford in Q4 2014, an estimated $88.3M increase.
  • Capital Growth Management's biggest Q4 2014 reduction was Marriott International, cutting an estimated $83M.
  • Capital Growth Management fully exited Gilead Sciences in Q4 2014, selling an estimated $166M.
  • Capital Growth Management's ten largest holdings make up 50% of its $3.63B portfolio in Q4 2014.
  • Capital Growth Management opened 22 new positions and closed 19 in Q4 2014.
  • Capital Growth Management's portfolio value rose 2.2% quarter-over-quarter to $3.63B.

Based on Capital Growth Management's 13F filing for Q4 2014, filed 13 Feb 2015.